Successful Surgical Hemostasis in Patients with von Willebrand Disease following Infusion of Koate®DVI

Successful Surgical Hemostasis in Patients with von Willebrand Disease following Infusion of Koate®DVI -

[1]  C. Kessler,et al.  Management of von Willebrand disease: a survey on current clinical practice from the haemophilia centres of North America , 2001, Haemophilia.

[2]  W. Dzik,et al.  The vWF content of factor VIII concentrates , 2001, Transfusion.

[3]  P. Mannucci,et al.  Impact, Diagnosis and Treatment of von Willebrand Disease , 2000, Thrombosis and Haemostasis.

[4]  M. Chandy,et al.  Haemostasis with cryoprecipitate in patients undergoing surgery for severe von Willebrand disease. , 2000, The National medical journal of India.

[5]  R. Kelley,et al.  The tissue factor region that interacts with substrates factor IX and Factor X. , 2000, Biochemistry.

[6]  T S Edgington,et al.  The mechanism of an inhibitory antibody on TF-initiated blood coagulation revealed by the crystal structures of human tissue factor, Fab 5G9 and TF.G9 complex. , 1998, Journal of molecular biology.

[7]  P. Foster.  A Perspective on the Use of FVIII Concentrates and Cryoprecipitate Prophylactically in Surgery or Therapeutically in Severe Bleeds in Patients with von Willebrand Disease Unresponsive to DDAVP: Results of an International Survey , 1995, Thrombosis and Haemostasis.

[8]  P. Mannucci,et al.  Patterns of development of tachyphylaxis in patients with haemophilia and von Willebrand disease after repeated doses of desmopressin (DDAVP) , 1992, British journal of haematology.

[9]  N. Mackman,et al.  Complete sequence of the human tissue factor gene, a highly regulated cellular receptor that initiates the coagulation protease cascade. , 1989, Biochemistry.

[10]  J. Miletich,et al.  Human tissue factor: cDNA sequence and chromosome localization of the gene. , 1987, Biochemistry.